Discontinued — last reported Q4 '23

Geographic · Non-Current Assets

Other foreign countries — Non-Current Assets

Eli Lilly Other foreign countries — Non-Current Assets increased by 9.7% to $1.78B in Q4 2023 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2023Feb 21, 2024
Rolls up toPP&E (Net)

How to read this metric

An increase suggests ongoing capital investment or infrastructure expansion in these regions, whereas a decrease may reflect asset depreciation, divestitures, or a strategic shift in regional operational focus.

Detailed definition

This metric measures the book value of long-term assets, such as property, plant, equipment, and intangible assets, phys...

Peer comparison

Comparable to 'Non-current assets by geography' reported by multinational pharmaceutical peers, reflecting the regional distribution of manufacturing and research infrastructure.

Metric ID: lly_segment_other_foreign_countries_noncurrent_assets

Historical Data

3 periods
 Q4 '21Q4 '22Q4 '23
Value$1.69B$1.63B$1.78B
QoQ Change-3.8%+9.7%
YoY Change-3.8%+9.7%
Range$1.63B$1.78B
Avg YoY Growth+2.9%
Median YoY Growth+2.9%

Frequently Asked Questions

What is Eli Lilly's other foreign countries — non-current assets?
Eli Lilly (LLY) reported other foreign countries — non-current assets of $1.78B in Q4 2023.
What does other foreign countries — non-current assets mean?
The total value of long-term, non-liquid assets held by the company in international markets outside of its primary reporting regions.